All Eyes On DOJ As Novartis FCA Deal Takes Shape
Novartis AG's tentative settlement Tuesday of kickback allegations for $390 million marked yet another huge False Claims Act payout that wasn't accompanied by punishment for individuals, and any final deal could indicate...To view the full article, register now.
Already a subscriber? Click here to view full article